Central Venous Catheterization News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Best Central Venous Catheter Location?Best Central Venous Catheter Location?
Which vein is associated with the fewest central venous catheter complications? Medscape Critical Care (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 7, 2016 Category: Surgery Tags: Critical Care Viewpoint Source Type: news
BiO2 Med miracle: Angel cath pivotal trial ends 1 year early
BiO2 Medical said today the pivotal clincial trial of its Angel catheter hit its target of 150 evaluable patients and has concluded a solid year earlier than anticipated.
The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company.
“We are very excited about completing this pivotal U.S. trial. We have found that physicians are very enthusiastic about an IVC filter that can be placed at the bedside in patients at very high risk for acute DVT / PE, or those with VTE who temporarily cannot be an...
Source: Mass Device - December 21, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Clinical Trials BiO2 Medical Source Type: news
Fewer Complications With Subclavian CatheterizationFewer Complications With Subclavian Catheterization
Central venous catheterization of the subclavian vein showed the lowest risks for bloodstream infections and symptomatic thrombosis compared with insertions at the jugular or femoral veins. Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 25, 2015 Category: Intensive Care Tags: Critical Care News Source Type: news
Central Venous Catheter Insertion: Is the Subclavian Vein the Safest Option? (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD
Catheterization of the subclavian vein is associated with lower risk for major catheter-related complications than insertion at the femoral or jugular vein, according to a New England Journal of Medicine study.Among adults … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 24, 2015 Category: Primary Care Source Type: news
Peripherally inserted central catheters can cause blood clots in lower limbs
Peripherally inserted central catheters (PICCs) are frequently used by healthcare professionals to obtain long-term central venous access in hospitalized patients. While there are numerous benefits associated with PICCs, a potential complication is deep vein thrombosis (DVT), or blood clots, in upper limbs. A new study of more than 70,000 patients in hospitals indicates that PICC use is associated not only with upper-extremity DVT, but also with lower-extremity DVT. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 17, 2015 Category: Science Source Type: news
Peripherally inserted central catheters can cause blood clots in lower limbs
(Elsevier Health Sciences) Peripherally inserted central catheters (PICCs) are frequently used by healthcare professionals to obtain long-term central venous access in hospitalized patients. While there are numerous benefits associated with PICCs, a potential complication is deep vein thrombosis (DVT), or blood clots, in upper limbs. A new study of more than 70,000 patients in 48 Michigan hospitals indicates that PICC use is associated not only with upper-extremity DVT, but also with lower-extremity DVT. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2015 Category: Global & Universal Source Type: news
Teleflex updates on Q2 earnings, FDA clearances, acquisitions, deals & study data.
This study, when combined with the 2 earlier independent studies by the same team, shows that using an Arrow CVC with antimicrobial protection from Teleflex makes sense from many perspectives. This study is further evidence that using an unprotected catheter may put both patients and a hospital’s bottom line at unnecessary risk. The Arrow CVC with Arrow+ard Technology has been repeatedly shown to improve patient safety even when the risk of infection is low, and it more than pays for itself in the process,” vascular access division prez Jay White said in a prepared statement.
The Arrow catheter also displaye...
Source: Mass Device - July 30, 2015 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Business/Financial News Cardiovascular Catheters Food & Drug Administration (FDA) MassDevice Earnings Roundup Mergers & Acquisitions Regulatory/Compliance Surgical Teleflex Source Type: news
BiO2 Medical raises $4m of $10m round
BiO2 Medical, developer of the Angel Catheter prophylactic pulmonary embolism protection device, said it raised $4 million, according to a regulatory filing.
The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company.
BiO2 Medical received $4 million of a hoped-for $10 million from 1 unnamed investor, according to an SEC filing.
In January, BiO2 won a nod from the FDA for a 182-patient pivotal trial of the device in patients at high risk for developing pulmonary embolism who can’t take standar...
Source: Mass Device - July 13, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters BiO2 Medical Source Type: news
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This weeks topics include persistent banned substances in supplements, knowledge of central venous catheters among physicians, vitamin D levels and different types of milk, and MD- versus hospital-owned practices and costs. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 25, 2014 Category: Primary Care Source Type: news
Healthcare Workers Often Unaware of Whether Patients Have Central Venous Catheters (FREE)
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Approximately one in five healthcare workers may not be able to recall whether their patients have central venous catheters (CVCs), according … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 21, 2014 Category: Primary Care Source Type: news
Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves
Bluegrass Vascular Technologies taps former ArthroCare R&D chief Gabriele Niederauer to be its new president & CEO.
Bluegrass Vascular Technologies said it named Gabriele Niederauer its new president & CEO, hard on the heels of a Series A funding round that brought in $4.5 million for its Surfacer central venous catheter.
ArthroCare Corp., Biolase Technology Inc., Bluegrass Vascular Technologies, Bovie Medical Corp., Copan Group, European Society of Cardiology, Evaluate Ltd., LED Medical Diagnostics Inc., Medina Medical, Novadaq, Philips Healthcare, Smith & Nephew, TYRX Inc.News Well, Pe...
Source: Mass Device - September 3, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news
A bumpy start ends on a high note for newborn August Koch
Bringing your newborn baby home from the hospital is a happy and momentous occasion. Tiny booties, frequent feedings and diaper changes, sleep adjustments and more are highlighted with warm snuggles, gentle kisses and family bonding time.
But for the Sundquist-Koch family, the happiness associated with those first few days as a new family took a sharp and unexpected turn soon after their son August Koch arrived home from the hospital.
At the tender age of 2 weeks old, August spiked a fever and needed to be seen at Beverly Hospital’s pediatric emergency department. Fortunately for August (and his very nervous parents Kate...
Source: Thrive, Children's Hospital Boston - July 30, 2014 Category: Pediatrics Authors: Maureen McCarthy Tags: All posts Beverly Hospital our patients' stories Source Type: news
Featured in NEJM Journal Watch: Reducing Central Venous Catheter Infection Rates (FREE)
By the NEJM Journal Watch Editors
Care … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 5, 2014 Category: Primary Care Source Type: news
There is No Such Thing As A Safe Execution
Never mind all that talk about Oklahoma’s botched execution of Clayton Lockett, who was supposed to be put to death yesterday by lethal injection, and instead died of a massive heart attack when one of the lines running into his arm blew out, causing the vein to rupture. He’s dead, ain’t he? Job done.
MoreOhio Ups Lethal-Injection Dosages After Controversial ExecutionMore Innocent People on Death Row Than Estimated: StudyMen Charged With Toppling Ancient Rock Formation Avoid Jail Time Huffington PostHere's An Updated Tally Of All The People Who Have Ever Died From A Marijuana Overdose Huffington PostWatch...
Source: TIME: Top Science and Health Stories - April 30, 2014 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized botched execution Death Penalty John Wayne Gacy justice lethal injection life imprisonment Murder Oklahoma Source Type: news
Duration of Central Catheter Use Drives Risk of Bloodstream Infections in Newborns - 11/11/13
A new study led by Johns Hopkins Children’s Center investigators shows that clinicians can reduce the risk of dangerous bloodstream infections in newborns with central venous catheters by ending use of the device as soon as possible, rather than waiting for signs of infection. (Source: Johns Hopkins Medicine News)
Source: Johns Hopkins Medicine News - November 11, 2013 Category: Research Source Type: news
